Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events

Research output: Contribution to journalJournal articleResearch

  • Antonella d'Arminio Monforte
  • Peter Reiss
  • Ryom, Lene
  • Wafaa El-Sadr
  • Francois Dabis
  • Stephane De Wit
  • Signe W Worm
  • Mathew G Law
  • Rainer Weber
  • Kirk, Ole
  • Christian Pradier
  • Andrew N Phillips
  • Lundgren, Jens
  • Caroline A Sabin
To investigate whether there is any association between exposure to atazanavir (ATV), either when boosted or unboosted by ritonavir, and myocardial infarction (MI) or stroke within the D:A:D: Study.
Original languageEnglish
JournalAIDS (London, England)
Volume27
Issue number3
Pages (from-to)407-15
Number of pages9
DOIs
Publication statusPublished - 28 Jan 2013

    Research areas

  • Adult, Aged, Australia, Comorbidity, Drug Therapy, Combination, Europe, Female, Follow-Up Studies, HIV Infections, HIV Protease Inhibitors, Humans, Incidence, Male, Middle Aged, Myocardial Infarction, Oligopeptides, Prospective Studies, Pyridines, Risk Factors, Ritonavir, Stroke, Time Factors, Treatment Outcome, United States, Viral Load

ID: 93928184